CN108715676A - A kind of novel biomaterial - Google Patents
A kind of novel biomaterial Download PDFInfo
- Publication number
- CN108715676A CN108715676A CN201810635565.5A CN201810635565A CN108715676A CN 108715676 A CN108715676 A CN 108715676A CN 201810635565 A CN201810635565 A CN 201810635565A CN 108715676 A CN108715676 A CN 108715676A
- Authority
- CN
- China
- Prior art keywords
- parts
- biomaterial
- raw material
- easy
- weight raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
- C08L2205/025—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/03—Polymer mixtures characterised by other features containing three or more polymers in a blend
- C08L2205/035—Polymer mixtures characterised by other features containing three or more polymers in a blend containing four or more polymers in a blend
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
A kind of novel biomaterial is made of following parts by weight raw material：28-40 parts of poly-lactic acid ester, 8-10 parts of fibrin, 1-3 parts of butanediol, 6-8 parts of gelatin, 2-4 parts of paraffin oil, 1-5 parts of antioxidant.Beneficial effects of the present invention are：(1) biomaterial performance during medicine use is stablized, not easy to break, is more in line with human body internal characteristic, and postoperative side reaction is few, and tensile strength and bending strength are high；(2) materials ingredient is simple and easy to get, at low cost, recycles convenient easily decomposition, will not cause damages to environment.
Description
Technical field
The invention belongs to field of new materials, and in particular to a kind of novel biomaterial.
Background technology
New material refers to some newly-developed or researching and developing, having preeminent performance materials, is had more than traditional material
For excellent performance.In recent years, new material is increasingly paid attention to, and country also payes attention to new material industry development.
New material technology is then the will according to people, passes through physical study, design of material, material processing, test evaluation etc.
A series of research process create the technology for the new material that can meet various needs.
Biomaterial belongs to one kind of forward position new material, and forward position new material carries out Disciplinary Frontiers standard Pre feasibility work in time
Make, coordinates, optimization key technical index, emphasis is around nano-powder material, graphene, superconductor and raw material, biomaterial
And the products such as product, intellectual material, 5 emphasis new material standard development works are completed, propose 10 emphasis standard research plans,
Carry out 30 standard Pre feasibilities, tight tracking world new material technology standard evolution trend carries out standard layout in advance.
Biomaterial is the diagnosis for tissue and organ, reparation or a kind of High-tech Material for promoting its function,
It is i.e. irreplaceable for replacing, repairing living tissue natural or artificial material, drugs with function.Biomaterial can execute, promote
Or certain function of being lost by disease, damage etc. is replaced, and rejected region cannot be restored.
Biomaterial (Biological materials) is also known as Biological Technology or biotechnology.Applied biology and work
The principle of Cheng Xue, to biomaterial, biology specific to function, directionally group build up the biological new varieties with specific trait
Comprehensive science and technology.Biotechnology is the beginning of the seventies, is developed on the basis ofs molecular biology, cell biology etc.
Come, including genetic engineering, cell engineering, enzyme engineering, Fermentation Engineering etc., they interknit, wherein using genetic engineering as base
Plinth.Only biology is transformed by genetic engineering, is possible to produce more better biological productions by the hope of the mankind
Product.And the achievement of genetic engineering also only is possible to be converted into product by engineerings such as fermentations.
It is broadly divided into according to purposes：Bear or transmit loading functional.1, such as artificial skelecton, joint and tooth, predominantly
Position；2, it controls blood or body fluid flows function, such as artificial valve, blood vessel；3, electricity, light, sound conduction function, such as cardiac pacing
Device, intraocular lens, cochlea etc.；4, function, such as cosmetic surgery obturator are filled.
Existing biomaterial is easily broken off, and performance in use is unstable, and human body is made to generate repulsion, is caused postoperative secondary anti-
It should compare more；And it is also comparatively laborious in terms of recycling, it is not easily decomposed, causes damages to environment.
Invention content
Purpose of the invention is to overcome the shortcomings in the prior art, provides a kind of novel biomaterial.For in solution
Technical problem is stated, the technical scheme is that：A kind of novel biomaterial is made of following parts by weight raw material：
Preferably, it is made of following parts by weight raw material：
Preferably, it is made of following parts by weight raw material：
Preferably, it is made of following parts by weight raw material：
Beneficial effects of the present invention are：(1) biomaterial performance during medicine use is stablized, not easy to break, more
Add and meet human body internal characteristic, postoperative side reaction is few, and tensile strength and bending strength are high；(2) materials ingredient is simple and easy to get, cost
It is low, convenient easily decomposition is recycled, will not be caused damages to environment.
Specific implementation mode
The effect of to make to structure feature of the invention and being reached, has a better understanding and awareness, to preferable
Embodiment cooperation detailed description, is described as follows：
Embodiment 1
A kind of novel biomaterial is made of following parts by weight raw material：
28 parts of poly-lactic acid ester, 8 parts of fibrin, 1 part of butanediol, 6 parts of gelatin, 2 parts of paraffin oil, 1 part of antioxidant.
Embodiment 2
A kind of novel biomaterial is made of following parts by weight raw material：
40 parts of poly-lactic acid ester, 10 parts of fibrin, 3 parts of butanediol, 8 parts of gelatin, 4 parts of paraffin oil, 5 parts of antioxidant.
Embodiment 3
A kind of novel biomaterial is made of following parts by weight raw material：
34 parts of poly-lactic acid ester, 9 parts of fibrin, 2 parts of butanediol, 7 parts of gelatin, 3 parts of paraffin oil, 3 parts of antioxidant.
Biomaterial obtained in embodiment 1-3 in the present invention is detected respectively, the results are shown in Table 1；
Table 1
Beneficial effects of the present invention are：(1) biomaterial performance during medicine use is stablized, not easy to break, more
Add and meet human body internal characteristic, postoperative side reaction is few, and tensile strength and bending strength are high；(2) materials ingredient is simple and easy to get, cost
It is low, convenient easily decomposition is recycled, will not be caused damages to environment.
The basic principles, main features and advantages of the present invention have been shown and described above.The technology of the industry
Personnel are it should be appreciated that the present invention is not limited to the above embodiments, and what is described in the above embodiment and the description is only the present invention
Principle, various changes and improvements may be made to the invention without departing from the spirit and scope of the present invention, these variation and
Improvement is both fallen in the range of claimed invention.The present invention claims protection domain by appended claims and its
Equivalent defines.
Claims (4)
1. a kind of novel biomaterial, it is characterised in that：It is made of following parts by weight raw material：
2. a kind of novel biomaterial according to claim 1, it is characterised in that：It is made of following parts by weight raw material：
3. a kind of novel biomaterial according to claim 1, it is characterised in that：It is made of following parts by weight raw material：
4. a kind of novel biomaterial according to claim 1, it is characterised in that：It is made of following parts by weight raw material：
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810635565.5A CN108715676A (en) | 2018-06-20 | 2018-06-20 | A kind of novel biomaterial |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810635565.5A CN108715676A (en) | 2018-06-20 | 2018-06-20 | A kind of novel biomaterial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108715676A true CN108715676A (en) | 2018-10-30 |
Family
ID=63912094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810635565.5A Pending CN108715676A (en) | 2018-06-20 | 2018-06-20 | A kind of novel biomaterial |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108715676A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105963802A (en) * | 2016-06-06 | 2016-09-28 | 湖州国信物资有限公司 | Anti-adhesion membrane for promoting wound healing |
| CN105999428A (en) * | 2016-06-15 | 2016-10-12 | 湖州科达化工燃料有限公司 | Anti-adhesion membrane with effects of resisting bacteria and stopping bleeding |
-
2018
- 2018-06-20 CN CN201810635565.5A patent/CN108715676A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105963802A (en) * | 2016-06-06 | 2016-09-28 | 湖州国信物资有限公司 | Anti-adhesion membrane for promoting wound healing |
| CN105999428A (en) * | 2016-06-15 | 2016-10-12 | 湖州科达化工燃料有限公司 | Anti-adhesion membrane with effects of resisting bacteria and stopping bleeding |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nicklas | Mitosis | |
| de Miguel-Beriain | The ethics of stem cells revisited | |
| CN108653809A (en) | A kind of composite hydrogel based on black phosphorus and gelatin and its application in terms of bone tissue engineer | |
| BR112012028265A2 (en) | method of grafting cells from solid tissues | |
| Srinivasan et al. | Exploring the current trends of artificial intelligence in stem cell therapy: a systematic review | |
| Nerem | Tissue engineering: confronting the transplantation crisis | |
| CN103497931A (en) | In-vivo tumor engineering human oophoroma tumor model established on basis of collagen aquogel | |
| CN106512065A (en) | Three-dimensional scaffold applied to cell culture and preparation method thereof | |
| Förster | Plea for a more systematic, comparative, international and long-term approach to restitution, provenance research and the historiography of collections | |
| CN108715676A (en) | A kind of novel biomaterial | |
| CN107028793A (en) | A kind of reparation stoste based on the human mesenchymal stem cell secretion activity factor and preparation method thereof | |
| Nadhif et al. | Reflecting on Mechanical Functionalities in Bioreactors for Tissue Engineering Purposes | |
| Song et al. | Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies | |
| CN106754647B (en) | A kind of separation, culture and the identification method of giant salamander skin epidermal cells | |
| CN209519145U (en) | Needle holder being applied to surgery Minimally nerve trachea | |
| CN208617901U (en) | A kind of separation of mouse articular chondrocytes, culture, identification kit | |
| CN107137339A (en) | Body frost of active factors extract secreted based on human mesenchymal stem cell and preparation method thereof | |
| CN104120104B (en) | A kind of production method of CD34+ cell | |
| CN101857853B (en) | Activin A-containing serum-free culture solution for industrially producing bioreactor tissue engineering active artificial skin and preparation method thereof | |
| CN107661569A (en) | One kind is used for the oxidation resistant stem cell processed material micropin of skin | |
| Xu | Research trends and progress in the field of metal materials and bone repair: Comprehensive bibliometric and visual analysis (2012–2021) | |
| CN103333859A (en) | Method for building in-situ model of transplantable mouse breast cancer tumor tissue block | |
| Lubowitz et al. | Saving our cells: Advances in tissue engineering for focal cartilage defects | |
| WANG | The birth and development of tissue engineering | |
| Ghaderi et al. | Preparation of rat's 3D-calvaria bone matrix and investigation of the intractions between L929 cell and this matrix. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181030 |